Department of Medicine, Royal college of Surgeons in Ireland - Medical University of Bahrain, Al Sayh Muharraq Governorate, Bahrain.
Department of Medicine, Royal Medical services, Bahrain Defense Force Hospital, Riffa, Bahrain.
Future Microbiol. 2020 Jul;15:897-903. doi: 10.2217/fmb-2020-0098. Epub 2020 Jul 8.
The diagnosis of novel coronavirus disease 2019 (COVID-19) has been a challenge in many countries due to nonspecific symptoms and variable incubation period. The current reference test is reverse transcriptase PCR. Many studies have reported high sensitivities of CT scans and suggested that they can be used in the diagnosis of COVID-19 alongside reverse transcriptase PCR. The current data about CT scans are highly variable and incoherent. Therefore, new multicentric studies in different countries are needed to better understand the role of CT scans in COVID-19 diagnosis. In this report, we will discuss the clinical relevance of each test and the current Centers for Disease Control and Prevention and American College of Radiology recommendations regarding the use of imaging in the diagnosis of COVID-19.
由于非特异性症状和可变的潜伏期,许多国家在诊断 2019 年新型冠状病毒病(COVID-19)方面一直面临挑战。目前的参考检测方法是逆转录酶聚合酶链反应(RT-PCR)。许多研究报告了 CT 扫描的高灵敏度,并提出可以将其与 RT-PCR 一起用于 COVID-19 的诊断。目前关于 CT 扫描的数据差异很大,缺乏一致性。因此,需要在不同国家开展新的多中心研究,以更好地了解 CT 扫描在 COVID-19 诊断中的作用。在本报告中,我们将讨论每种检测的临床相关性,以及目前美国疾病控制与预防中心和美国放射学院关于在 COVID-19 诊断中使用影像学的建议。